Name: prostate cancer (en Inglés)
Price: 147900.00 CLP
Availability: InStock
Author: Duncan, William
ISBN: 9783642816239

Formato

Libro Físico

Ilustrado por

William Duncan

Editorial

Springer

Autor

Duncan, William

Año

2011

Idioma

Inglés

N° páginas

192

Encuadernación

Tapa Blanda

Dimensiones

24.4 x 17.0 x 1.1 cm

Peso

0.34 kg.

ISBN

3642816231

ISBN13

9783642816239

Categorías

Oncología
Urología y medicina urogenital

prostate cancer (en Inglés)

William Duncan (Ilustrado por) · Springer · Tapa Blanda

Libro Nuevo

$ 147.900

$ 246.500

Ahorras: $ 98.600

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 31 de Mayo y el Miércoles 12 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "prostate cancer (en Inglés)"

In February 1980 the Royal College of Radiologists, London, held its Second Symposium on Clinical Oncology. The subject was Prostatic Cancer and this publication is based on the presen- tations at this meeting by leading authorities in the United Kingdom. The principal objective of these Symposia is to promote multi- disciplinary collaboration for the benefit of cancer patients. Awareness and understanding of advances in a broad range of subjects are essential to ensure the timely and effective appli- cation of new techniques in the prevention and treatment of all forms of cancer. Communication of this kind may also stimulate the creation of new ideas that may prove to be of more fundamental relevance to cancer research. Prostatic cancer has been afforded too little attention in the past, and its importance in Clinical Oncology has not been adequately recognised. And yet over the last 10 years consid- erable progress has been recorded in our understanding of this disease and in its assessment and management. These achieve- ments are well documented in this collection of papers and the outstanding problems are also clearly indicated. It is acknowl- edged that the early diagnosis of prostatic cancer presents a continuing challenge, associated with the uncertainties that concern the clinical significance of 'latent' cancer of the prostate. The accurate assessment of the incidence and preva- lence of the disease is extremely difficult and together these problems complicate the evaluation of the management of early or localised prostatic cancer.